Takashi Suda

12.1k total citations · 6 hit papers
83 papers, 10.2k citations indexed

About

Takashi Suda is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Takashi Suda has authored 83 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 45 papers in Immunology and 15 papers in Cancer Research. Recurrent topics in Takashi Suda's work include Cell death mechanisms and regulation (30 papers), Inflammasome and immune disorders (23 papers) and NF-κB Signaling Pathways (15 papers). Takashi Suda is often cited by papers focused on Cell death mechanisms and regulation (30 papers), Inflammasome and immune disorders (23 papers) and NF-κB Signaling Pathways (15 papers). Takashi Suda collaborates with scholars based in Japan, United States and France. Takashi Suda's co-authors include Shigekazu Nagata, Tomohiro Takahashi, Masato Tanaka, Pierre Golstein, Nancy A. Jenkins, Neal G. Copeland, Ryu Imamura, Takeshi Kinoshita, Takayuki Takahashi and Norio Nakamura and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Takashi Suda

80 papers receiving 10.1k citations

Hit Papers

Molecular cloning and exp... 1993 2026 2004 2015 1993 1994 1996 1995 1995 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
    1993 2.2k citations Takashi Suda, Tomohiro Takahashi et al. Cell profile →
  2. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
    1994 1.3k citations Tomohiro Takahashi, Masato Tanaka et al. Cell profile →
  3. Fas ligand in human serum
    1996 601 citations Masato Tanaka, Takashi Suda et al. Nature Medicine profile →
  4. Expression of the Fas ligand in cells of T cell lineage.
    1995 580 citations Takashi Suda, Shigekazu Nagata et al. The Journal of Immunology profile →
  5. Expression of the functional soluble form of human fas ligand in activated lymphocytes.
    1995 562 citations Masato Tanaka, Takashi Suda et al. profile →
  6. Caspase-1 initiates apoptosis in the absence of gasdermin D
    2019 375 citations K. Tsuchiya, Takeshi Kinoshita et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takashi Suda Japan 41 5.7k 5.5k 1.4k 1.3k 1.0k 83 10.2k
Westley H. Reeves United States 57 3.4k 0.6× 5.1k 0.9× 1.2k 0.9× 1.2k 1.0× 1.0k 1.0× 209 10.3k
Ann Marshak‐Rothstein United States 59 4.8k 0.8× 12.0k 2.2× 1.4k 1.0× 1.0k 0.8× 1.1k 1.1× 180 15.7k
Sergei A. Nedospasov Russia 60 4.1k 0.7× 6.4k 1.2× 2.0k 1.5× 1.1k 0.9× 1.7k 1.7× 239 12.2k
Barbara Bottazzi Italy 67 3.8k 0.7× 10.9k 2.0× 1.9k 1.4× 1.2k 1.0× 842 0.8× 196 14.5k
Carlo Laudanna Italy 39 3.3k 0.6× 5.0k 0.9× 1.6k 1.2× 627 0.5× 663 0.7× 94 10.1k
Reinhard Voll Germany 54 4.5k 0.8× 8.0k 1.5× 1.6k 1.2× 970 0.8× 1.3k 1.3× 244 13.7k
Sussan Nourshargh United Kingdom 55 4.1k 0.7× 6.5k 1.2× 1.5k 1.1× 875 0.7× 847 0.8× 132 13.2k
Ian Dransfield United Kingdom 50 3.5k 0.6× 6.3k 1.1× 1.1k 0.8× 799 0.6× 659 0.6× 132 10.7k
John J. Letterio United States 57 5.2k 0.9× 5.2k 1.0× 3.1k 2.3× 689 0.5× 1.1k 1.0× 122 12.8k
Antonella Stoppacciaro Italy 50 4.3k 0.8× 4.7k 0.9× 2.9k 2.1× 610 0.5× 1.3k 1.2× 160 10.8k

Countries citing papers authored by Takashi Suda

Since Specialization
Citations

This map shows the geographic impact of Takashi Suda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Suda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Suda more than expected).

Fields of papers citing papers by Takashi Suda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Suda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Suda. The network helps show where Takashi Suda may publish in the future.

Co-authorship network of co-authors of Takashi Suda

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Suda. A scholar is included among the top collaborators of Takashi Suda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Suda. Takashi Suda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dodo, Kosuke, Tadashi Shimizu, Ryu Imamura, et al.. (2019). Development of a Water-Soluble Indolylmaleimide Derivative IM-93 Showing Dual Inhibition of Ferroptosis and NETosis. ACS Medicinal Chemistry Letters. 10(9). 1272–1278. 8 indexed citations
2.
Zhang, Peipei, K. Tsuchiya, Takeshi Kinoshita, et al.. (2016). Vitamin B6 Prevents IL-1β Protein Production by Inhibiting NLRP3 Inflammasome Activation. Journal of Biological Chemistry. 291(47). 24517–24527. 89 indexed citations
3.
Harashima, Nanae, et al.. (2011). Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Cancer Immunology Immunotherapy. 61(5). 667–676. 58 indexed citations
4.
Imamura, Ryu, Yetao Wang, Takeshi Kinoshita, et al.. (2010). Anti-Inflammatory Activity of PYNOD and Its Mechanism in Humans and Mice. The Journal of Immunology. 184(10). 5874–5884. 78 indexed citations
5.
Motani, Kou, et al.. (2010). Activation of ASC induces apoptosis or necrosis, depending on the cell type, and causes tumor eradication. Cancer Science. 101(8). 1822–1827. 22 indexed citations
6.
Kinoshita, Takahiro, et al.. (2009). Fas-Associated Factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1. Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University). 18 indexed citations
7.
Imamura, Ryu, et al.. (2007). Caspase-8- and JNK-dependent AP-1 activation is required for Fas ligand-induced IL-8 production. Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University). 37 indexed citations
8.
Umemura, Masayuki, Ayano Yahagi, Satoru Hamada, et al.. (2007). IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guerin Infection. The Journal of Immunology. 178(6). 3786–3796. 439 indexed citations
9.
Hasegawa, Minoru, Kodo Kawase, Naohiro Inohara, et al.. (2007). Mechanism of ASC-mediated apoptosis : Bid-dependent apoptosis in type II cells. Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University). 42 indexed citations
10.
Hasegawa, Mizuho, Ryu Imamura, Takeshi Kinoshita, et al.. (2006). ASC-mediated NF-κB Activation Leading to IL-8 Production Requires Caspase-8 and Is Inhibited by CLARP. 2003. 117.
11.
Kasmi, Karim C. El, Jeff Holst, Maryaline Coffre, et al.. (2006). General Nature of the STAT3-Activated Anti-Inflammatory Response. The Journal of Immunology. 177(11). 7880–7888. 186 indexed citations
12.
Kidoya, Hiroyasu, Masayuki Umemura, Goro Matsuzaki, et al.. (2005). Fas Ligand Induces Cell-Autonomous IL-23 Production in Dendritic Cells, a Mechanism for Fas Ligand-Induced IL-17 Production. The Journal of Immunology. 175(12). 8024–8031. 17 indexed citations
13.
Imamura, Ryu, Mizuho Hasegawa, Masayuki Fukui, et al.. (2004). Fas Ligand Induces Cell-autonomous NF-κB Activation and Interleukin-8 Production by a Mechanism Distinct from That of Tumor Necrosis Factor-α. Journal of Biological Chemistry. 279(45). 46415–46423. 88 indexed citations
14.
Fukui, Masayuki, et al.. (2003). Pathogen-Associated Molecular Patterns Sensitize Macrophages to Fas Ligand-Induced Apoptosis and IL-1β Release. The Journal of Immunology. 171(4). 1868–1874. 48 indexed citations
15.
Nakamoto, Yasunari, Shuichi Kaneko, Hong Fan, et al.. (2002). Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy. The Journal of Experimental Medicine. 196(8). 1105–1111. 59 indexed citations
16.
Shimizu, Hideyuki, Tetsuya Matsuguchi, Yoshihide Fukuda, et al.. (2002). Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology. 123(4). 1265–1277. 43 indexed citations
17.
Ishimaru, Naozumi, Kumiko Yanagi, Kouichi Ogawa, et al.. (2001). Possible Role of Organ-Specific Autoantigen for Fas Ligand-Mediated Activation-Induced Cell Death in Murine Sjogren’s Syndrome. The Journal of Immunology. 167(10). 6031–6037. 25 indexed citations
18.
Suda, Takashi. (1999). [Molecular mechanisms and biological roles of apoptosis and inflammation induced by Fas ligand].. PubMed. 44(10). 1477–86. 2 indexed citations
19.
Tanaka, Masato, Takashi Suda, Kyosuke Haze, et al.. (1996). Fas ligand in human serum. Nature Medicine. 2(3). 317–322. 601 indexed citations breakdown →
20.
Takahashi, Tomohiro, Masato Tanaka, Nancy A. Jenkins, et al.. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell. 76(6). 969–976. 1317 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Westley H. Reeves Breakdown of academic impact, for papers by Ann Marshak‐Rothstein Breakdown of academic impact, for papers by Sergei A. Nedospasov Breakdown of academic impact, for papers by Barbara Bottazzi Breakdown of academic impact, for papers by Carlo Laudanna Breakdown of academic impact, for papers by Reinhard Voll Breakdown of academic impact, for papers by Sussan Nourshargh Breakdown of academic impact, for papers by Ian Dransfield Breakdown of academic impact, for papers by John J. Letterio Breakdown of academic impact, for papers by Antonella Stoppacciaro
Rankless by CCL
2026